Anti-inflammatory effect of diosmectite in hapten-induced colitis in the rat

British Journal of Pharmacology

Volumn 141, Issue 6, 2004, Pages 951-960

  González, Raquel ^a   Sánchez De Medina, Fermin ^a   Martínez Augustin, Olga ^a   Nieto, Ana ^b   Gálvez, Julio ^a   Risco, Severiano ^a   Zarzuelo, Antonio ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Diosmectite; Experimental colitis; Inflammatory bowel disease; Trinitrobenzenesulphonic acid

Indexed keywords

ANTIINFLAMMATORY AGENT; BACTERIUM LIPOPOLYSACCHARIDE; BIOCHEMICAL MARKER; DIOSMECTITE; GLUTATHIONE; HAPTEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LEUKOTRIENE B4; MESSENGER RNA; MUCIN 2; MYELOPEROXIDASE; SALAZOSULFAPYRIDINE; SILICATE; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD RHEOLOGY; CELL STRAIN HT29; COLITIS; COLON; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIARRHEA; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INTESTINE NECROSIS; MORPHOLOGICAL TRAIT; MUCOSA CELL; MUCUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA TRANSCRIPTION; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL LINE; COLITIS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE; GLYCOPROTEINS; HAPTENS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; LEUKOTRIENE B4; MUCINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; SILICATES; TRINITROBENZENESULFONIC ACID;

EID: 11144354252     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705710     Document Type: Article

References (44)

1. ADAMS, R.B., PLANCHON, S.M. & ROCHE, J.K. (1993). IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J. Immunol., 150, 2356-2363.
2. AKERBOOM, T.P. & SIES, H. (1981). Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol., 77, 373-382.
3. ALBENGRES, E., URIEN, S., TILLEMENT, J.P., OURY, P., DECOURT, S., FLOUVAT, B. & DRIEU, K. (1985). Interactions between smectite, a mucus stabilizer, and acidic and basic drugs. In vitro and in vivo studies. Eur. J. Clin. Pharmacol., 28, 601-605.
4. ASFAHA, S., MACNAUGHTON, W.K., APPLEYARD, C.B., CHADEE, K. & WALLACE, J.L. (2001). Persistent epithelial dysfunction and bacterial translocation after resolution of intestinal inflammation. Am. J. Physiol. Gastrointest. Liver Physiol., 281, G635-G644.
5. BELL, C.J., GALL, D.G. & WALLACE, J.L. (1995). Disruption of colonic electrolyte transport in experimental colitis. Am. J. Physiol., 268, G622-G630.
6. BELL, S. & KLAMM, M.A. (2000). Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease. Lancet, 355, 858-860.
7. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
8. BRENNAN, F.M., MAINI, R.N. & FELDMANN, M. (1995). Cytokine expression in chronic inflammatory disease. Br. Med. Bull., 51, 368-384.
9. CASTRO, G.A. & POWELL, D.W. (1994). The physiology of the mucosal immune system and immune-mediated responses in the gastrointestinal tract. In: Physiology of the Gastrointestinal Tract, ed. Johnson, L.R., Alpers, D.A., Christensen, J., Jacobson, E.D. & Walsh, J.H. pp. 709-750. New York: Raven Press.
10. DROY, M.T., DROUET, Y., GERAUD, G. & SCHATZ, B. (1985). Spinnability: a new approach to intestinal stress and its therapy. Gastroenterol. Clin. Biol., 9, 119-121.
11. DUPONT, C., MORENO, J.L., BARAU, E., BARGAOUI, K., THIANE, E. & PLIQUE, O. (1992). Effect of diosmectite on intestinal permeability changes in acute diarrhea: a double-blind placebo-controlled trial. J. Pediatr. Gastroenterol. Nutr., 14, 413-419.
12. FIOCCHI, C. (1998). Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology, 115, 182-205.
13. FIORAMONTI, J., DROY-LEFAIX, M.T. & BUENO, L. (1987). Changes in gastro intestinal motility induced by cholera toxin and experimental osmotic diarrhoea in dogs: effects of treatment with an argillaceous compound. Digestion, 36, 230-237.
14. FIORAMONTI, J., NAVETAT, H., DROY-LEFAIX, M.T. & BUENO, L. (1990). Antidiarrheal properties of clay minerals: pharmacological and clinical studies. In: Veterinary Pharmacology, Toxicology and Therapy in Food Producing Animals, ed. Simon, F., Less, P. & Semjen, G. pp. 245-251. Budapest: Unipharma.
15. GARDINER, K.R., ANDERSON, N.H., MCCAIGUE, M.D., ERWIN, P.J., HALLIDAY, M.I. & ROWLANDS, B.J. (1993). Adsorbents as antiendotoxin agents in experimental colitis. Gut, 34, 51-55.
16. GUARINO, A., BISCEGLIA, M., CASTELLUCCI, G., IACONO, G., CASALI, L.G., BRUZZESE, E., MUSETTA, A. & GRECO, L. (2001). Smectite in the treatment of acute diarrhea: a nationwide randomized controlled study of the Italian Society of Pediatric Gastroenterology and Hepatology (SIGEP) in collaboration with primary care pediatricians. SIGEP Study Group for Smectite in Acute Diarrhea. J. Pediatr. Gastroenterol. Nutr., 32, 71-75.
17. HERSHBERG, R.M. & MAYER, L.F. (2000). Antigen processing and presentation by intestinal epithelial cells-polarity and complexity. Immunol. Today, 21, 123-128.
18. HEYMAN, M., DARMON, N., DUPONT, C., DUGAS, B., HIRRIBAREN, A., BLATON, M.A. & DESJEUX, J.F. (1994). Mononuclear cells from infants allergic to cow's milk secrete tumour necrosis factor alpha, altering intestinal function. Gastroenterology, 106, 1514-1523.
19. HEYMAN, M. & DESJEUX, J.F. (1992). Significance of intestinal food protein transport. J. Pediatr. Gastroenterol. Nutr., 15, 48-57.
20. HOLLANDER, D., VADHEIM, C.M., BRETTHOLZ, E., PETERSEN, G.M., DELAHUNTY, T. & ROTTER, J.I. (1986). Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor. Ann. Intern. Med., 105, 883-885.
21. JUNG, H.C., ECKMANN, L., YANG, S.K., PANJA, A., FIERER, J., MORZYCKA-WROBLEWSKA, E. & KAGNOFF, M.F. (1995). A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest., 95, 55-65.
22. KERR, S.W., WOLYNIEC, W.W., FILIPOVIC, Z., NODOP, S.G., BRAZA, F., WINQUIST, R.J. & NOONAN, T.C. (1999). Repeated measurement of intestinal permeability as an assessment of colitis severity in HLA-B27 transgenic rats. J. Pharmacol. Exp. Ther., 291, 903-910.
23. KRAWISZ, J.E., SHARON, P. & STENSON, W.F. (1984). Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology, 87, 1344-1350.
24. LEONARD, A., DROY-LEFAIX, M.T. & ALLEN, A. (1994). Pepsin hydrolysis of the adherent mucus barrier and subsequent gastric mucosal damage in the rat: effect of diosmectite and 16,16 dimethyl prostaglandin E2. Gastroenterol. Clin. Biol., 18, 609-616.
25. MADKOUR, A.A., MADINA, E.M., EL-AZZOUNI, O.E., AMER, M.A., EL-WALILI, T.M. & ABBASS, T. (1993). Smectite in acute diarrhea in children: a double-blind placebo-controlled clinical trial. J. Pediatr. Gastroenterol. Nutr., 17, 176-181.
26. MAHRAOUI, L., HEYMAN, M., PLIQUE, O., DROY-LEFAIX, M.T. & DESJEUX, J.F. (1997). Apical effect of diosmectite on damage to the intestinal barrier induced by basal tumour necrosis factor-alpha. Gut, 40, 339-343.
27. MATHAN, M.M., CHANDY, G. & MATHAN, V.I. (1995). Ultrastructural changes in the upper small intestinal mucosa in patients with cholera. Gastroenterology, 109, 422-430.
28. MORE, J., BENAZET, F., FIORAMONTI, J. & DROY-LEFAIX, M.T. (1987). Effects of treatment with smectite on gastric and intestinal glycoproteins in the rat: a histochemical study. Histochem. J., 19, 665-670.
29. MORRIS, G.P., BECK, P.L., HERRIDGE, M.S., DEPEW, W.T., SZEWCZUK, M.R. & WALLACE, J.L. (1989). Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology, 96, 795-803.
30. MUSCH, M.W. & CHANG, E.B. (1994). Diarrhea in inflammatory bowel diseases. In: Inflammatory Bowel Disease: From Bench to Bedside, ed. Targan, S.R. & Shanahan, F. pp. 239-254. Baltimore: Williams & Wilkins.
31. POWELL, D.W. (1994). New paradigms for the pathophysiology of infectious diarrhea. Gastroenterology, 106, 1705-1707.
32. RATEAU, J.G., MORGANT, G., DROY-PRIOT, M.T. & PARIER, J.L. (1982). A histological, enzymatic and water-electrolyte study of the action of smectite, a mucoprotective clay, on experimental infectious diarrhoea in the rabbit. Curr. Med. Res. Opin., 8, 233-241.
33. SANCHEZ DE MEDINA, F., PEREZ, R., MARTINEZ-AUGUSTIN, O., GONZALEZ, R., LORENTE, M.D., GALVEZ, J. & ZARZUELO, A. (2002a). Disturbances of colonic ion secretion in inflammation: role of the enteric nervous system and cAMP. Pflugers Arch., 444, 378-388.
34. SANCHEZ DE MEDINA, F., VERA, B., GALVEZ, J. & ZARZUELO, A. (2002b). Effect of quercitrin on the early stages of hapten induced colonic inflammation in the rat. Life Sci., 70, 3097-3108.
35. SANDLER, R.S. (1994). Epidemiology of inflammatory bowel diseases. In: Inflammatory Bowel Disease: From Bench to Bedside, ed. Targan, S.R. & Shanahan, F. pp. 5-30. Baltimore: Williams & Wilkins.
36. SANDS, B.E. (2000). Therapy of inflammatory bowel disease. Gastroenterology, 118, S68-S82.
37. SHIRAZI, T., LONGMAN, R.J., CORFIELD, A.P. & PROBERT, C.S. (2000). Mucins and inflammatory bowel disease. Postgrad. Med. J., 76, 473-478.
38. STROBER, W. & FUSS, I.J. (1999). Experimental models of inflammation and their relation to human inflammatory bowel disease. In: Intestinal Mucosa and its Diseases. Pathophysiology and Clinics, ed. Domschke, W., Stoll, R., Brasitus, T.A. & Kagnoff, M.F. pp. 457-470. Dordrecht, The Netherlands: Kluwer Academic Publishers BV.
39. STUCCHI, A.F., SHOFER, S., LEEMAN, S., MATERNE, O., BEER, E., MCCLUNG, J., SHEBANI, K., MOORE, F., O'BRIEN, M. & BECKER, J.M. (2000). NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am. J. Physiol. Gastrointest. Liver Physiol., 279, G1298-G1306.
40. THEODOROU, V., FIORAMONTI, J., DROY-LEFAIX, M.T., PLIQUE, O. & BUENO, L. (1994). Protective action of diosmectite treatment on digestive disturbances induced by intestinal anaphylaxis in the guinea-pig. Aliment. Pharmacol. Ther., 8, 295-299.
41. TODA, Y., TSUKADA, J., MISAGO, M., KOMINATO, Y., AURON, P.E. & TANAKA, Y. (2002). Autocrine induction of the human pro-IL-1beta gene promoter by IL-1beta in monocytes. J. Immunol., 168, 1984-1991.
42. TYTGAT, K.M., BOVELANDER, F.J., OPDAM, F.J., EINERHAND, A.W., BULLER, H.A. & DEKKER, J. (1995). Biosynthesis of rat MUC2 in colon and its analogy with human MUC2. Biochem. J., 309, 221-229.
43. TYTGAT, K.M., VAN DER WAL, J.W., EINERHAND, A.W., BULLER, H.A. & DEKKER, J. (1996). Quantitative analysis of MUC2 synthesis in ulcerative colitis. Biochem. Biophys. Res. Commun., 224, 397-405.
44. WARHOLM, M., GUTHENBERG, C., VON BAHR, C. & MANNERVIK, B. (1985). Glutathione transferases from human liver. Methods Enzymol., 113, 499-504.